Magnetic nanosystem for cancer therapy using oncocalyxone A, an antitomour secondary metabolite isolated from a Brazilian plant

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18269-18283

  Barreto, Antônio C H ^a   Santiago, Vivian R ^a   Freire, Rafael M ^a   Mazzetto, Selma E ^a   Denardin, Juliano C ^b   Mele, Giuseppe ^c   Cavalcante, Igor M ^a   Ribeiro, Maria E N P ^a   Ricardo, Nágila M P S ^a   Gonçalves, Tamara ^a   Carbone, Luigi ^d   Lemos, Telma L G ^a   Pessoa, Otília D L ^a   Fechine, Pierre B A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF SALENTO   (Italy)

^d NATIONAL NANOTECHNOLOGY LABORATORY   (Italy)

Author keywords

Cancer therapy; Drug delivery; Magnetic nanoparticles; Oncocalyxone A

Indexed keywords

ETHYLENE OXIDE; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; ONCOCALYXONE A; PLANT MEDICINAL PRODUCT; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STORAGE; MICELLE; NANOENCAPSULATION; PARTICLE SIZE;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; BORAGINACEAE; DRUG DELIVERY SYSTEMS; MAGNETICS; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84883625575     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918269     Document Type: Article

References (39)

1. Pessoa, O.D.L.; de Lemos, T.L.G.; Silveira, E.R.; Braz-Filho, R. Novel cordiachromes isolated from Auxemma oncocalyx. Nat. Prod. Lett. 1993, 2, 145-150.
2. Ferreira, M.A.D.; Nunes, O.D.R.H.; Fentenele, J.B.; Pessoa, O.D.L.; de Lemos, T.L.G.; Viana, G.S.B. Analgesic and anti-inflammatory activities of a fraction rich in oncocalyxone A isolated from Auxemma oncocalyx. Phytomedicine 2004, 11, 315-322.
3. Ferreira, M.A.D.; Nascimento, N.R.F.; Sousa, C.M.; Pessoa, O.D.L.; de Lemos, T.L.G.; Ventura, J.S.; Schattner, M.; Chudzinski-Travassi, A.M. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibα glycoprotein. Br. J. Pharmacol. 2008, 154, 1216-1224.
4. Pessoa, O.D.L.; de Lemos, T.L.G.; de Carvalho, M.G.; Braz-Filho, R. Cordiachoromes from Auxemma oncocalyx. Phytochemistry 1995, 40, 1777-1786.
5. Marques, W.B.; dos Santos, H.S.; Pessoa, O.D.L.; Braz-Filho, R.; de Lemos, T.L.G. Anthracene derivatives from Auxemma oncocalyx. Phytochemistry 2000, 55, 793-797.
6. Costa, C.O.C.; Souza, A.A.; Luz, R.C.S.; de Lemos, T.L.G.; Pessoa, O.D.L.; Kubota, L.T.; Goulart, M.O.F. Eletrochemical determination of Oncocalyxone A using an iron-phthalocyanine/iron-porphirin modified glassy carbon electrode. J. Braz. Chem. Soc. 2008, 19, 697-703.
7. Alexiou, C.; Schmid, R.J.; Jurgons, R.; Kremer, M.; Wanner, G.; Bergemann, C.; Huengens, E.; Nawroth, T.; Arnold, W.; Parak, F.G. Targeting cancer cells: Magnetic nanoparticles as drug carriers. Eur. Biophys. J. 2006, 35, 446-450.
8. Jain, T.P.; Morales, M.A.; Sahoo, S.K.; Pelecki, D.L.L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharmaceut. 2005, 2, 194-205.
9. Voltairas, P.A.; Fotiadis, D.I.; Michalis, L.K. Hydrodynamics of magnetic drug targeting. J. Biomech. 2002, 35, 813-821.
10. Hu, F.X.; Neoh, K.G.; Kang, E.T. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 2006, 27, 5725-5733.
11. Giri, J.; Pradhan, P.; Somani, V.; Chelawat, H.; Chhatre, S.; Banerjee, R.; Bahadur, D. Synthesis and characterizations of water-based ferrofluids of substituted ferrites [Fe1-xBxFe2O4, B = Mn, Co (x = 0-1)] for biomedical applications. J. Mag. Mag. Mater. 2008, 320, 724-730.
12. Shubayev, V.I.; Pisanic, T.R., II; Jin, S. Magnetic nanoparticles for theragnostics. Adv. Drug Deliver. Ver. 2009, 61, 467-477.
13. Barreto, A.C.H.; Santiago, V.R.; Mazzetto, S.E.; Denardin, J.C.; Lavín, R.; Mele, G.; Ribeiro, M.E.N.P.; Vieira, I.G.P.; Gonçalves, T.; Ricardo, N.M.P.S.; et al. Magnetic nanoparticles for a new drug delivery system to control quercetin for cancer chemotherapy. J. Nanopart. Res. 2011, 13, 6545-6553.
14. Boyer, C.; Whittaker, M.R.; Bulmus, V.; Liu, J.; Davis, T.P. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater. 2010, 2, 23-30.
15. Doraiswamy, P.M.; Finefrock, A.E. Metals in our minds: Therapeutic implications for neurodegenerative disorders. Lanc. Neur. 2004, 3, 431-434.
16. Gupta, A.K.; Curtis, A.S.G. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 2004, 15, 493-496.
17. Wang, Y.; Ng, W.Y.; Chen, Y.; Shuter, B.; Yi, J.; Ding, J.; Wang, S.C.; Feng, S.S. Formulation of superparamagnetic iron oxides by nanoparticles of biodegradable polymers for magnetic resonance imaging. Adv. Funct. Mater. 2008, 18, 308-318.
18. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R.N. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Ver. 2008, 108, 2064-2110.
19. Cavalcante, I.M. Micelas de Copolímeros em Bloco para Administração de Fármacos Hidrofóbicos: Caraterização, Solubilização e Liberação. Ph.D. Thesis, Federal University of Ceará, Fortaleza, Brazil, 2009.
20. Pessoa, C.; Silveira, E.R.; de Lemos, T.L.G.; Wetmore, L.A.; Moraes, M.O.; Leyva, A. Antiproliferative effects of compounds derived from plants of Northeast Brazil. Phytother. Res. 2000, 14, 187-191.
21. Leyva, A.; Pessoa, C.; Boogaerdt, F.; Sokaroski, R.; de Lemos, T.L.G.; Wetmore, L.A.; Huruta, R.R.; Moraes, M.O. Oncocalyxones A and C, 1,4-anthracenediones from Auxemma oncocalyx: Comparison with anticancer 1,9-anthracenediones. Anticancer Res. 2000, 20, 1029-1031.
22. Costa-Lotufo, L.V.; Ferreira, M.A.D.; de Lemos, T.L.G.; Pessoa, O.D.L.; Viana, G.S.B.; Cunha, G.M.A. Toxicity to sea urchin egg development of the quinone fraction obtained from Auxemma oncoalyx. Braz. J. Med. Biol. Res. 2002, 35, 927-930.
23. Braga, T.P.; Vasconcelos, I.F.; Sasaki, J.M.; Fabris, J.D.; Oliveira, D.Q.L.; Valentini, A. Magnetic composites base on hybrid spheres of aluminum oxide and superparamagnetic nanoparticles of iron oxides. J. Mag. Mag. Mater. 2010, 322, 633-637.
24. Kumari, A.; Yadav, S.K.; Pakade, Y.B.; Singh, B.; Yadav, S.C. Development of biodegradable nanoparticles for delivery of quercetin. Colloids Surf. B 2010, 80, 184-192.
25. Hrdina, A.; Lai, E.; Li, C.; Sadi, B.; Kramer, G. A comparative study of magnetic transferability of superparamagnetic nanoparticles. J. Mag. Mag. Mater. 2010, 322, 2622-2627.
26. Slavov, L.; Abrashev, M.V.; Merodiiska, T.; Gelev, Ch.; Vandenberghe, R.E.; Markova-Deneva, I.; Nedkov, I. Raman spectroscopy investigation of magnetite nanoparticles in ferrofluids. J. Mag. Mag. Mater. 2010, 322, 1904-1911.
27. Chinnasamy, C.N.; Narayanasamy, A.; Ponpandian, N. Mixed spinel structure in nanocrystalline NiFe2O4. Phys. Rev. B 2001, 63, 184108.
28. Cao, H.; He, J.; Deng, L.; Gao, X. Fabrication of cyclodextrin-functionalized superparamagnetic Fe3O4/amino-silane core-shell nanoparticles via layer-by-layer method. Appl. Surf. Sci. 2009, 255, 7974-7980.
29. Ying, X.Y.; Du, Y.Z.; Hong, L.H.; Yuan, H.; Hu, F.Q. Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: Preparation and characteristics. J. Mag. Mag. Mater. 2011, 323, 1088-1093.
30. Wei, Y.; Han, B.; Hu, X.; Lin, Y.; Wang, X.; Deng, X. Synthesis of Fe3O4 nanoparticles and their magnetic properties. Procedia Eng. 2012, 27, 632-637.
31. Ilgin, P.; Avci, G.; Silan, C.; Ekici, S.; Aktas, N.; Ayyala, R.S.; John, V.T.; Sahiner, N. Colloidal drug carries from (sub)micron hyaluronic acid hydrogel particles with tunable properties for biomedical applications. Carbohydr. Polym. 2010, 82, 997-1003.
32. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50, 874-875.
33. Korsmeyer, R.W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15, 25-35.
34. Manadas, R.; Pina, M.E.; Veiga, F. A dissolução in vitro na previsão da absorção oral de fármacos em formas farmacêuticas de liberação modificada. Braz. J. Pharm. Sci. 2002, 38, 375-399.
35. Lopes, C.M.; Lobo, J.M.S.; Costa, P. Formas farmacêuticas de liberação modificada: Polímeros hidrifílicos. Braz. J. Pharm. Sci. 2005, 41, 143-154.
36. Nappini, S.; Bombelli, F.B.; Bonini, M.; Nordèn, B.; Baglioni, P. Magnetoliposomes for controlled drug release in the presence of low frequency magnetic field. Soft. Matter. 2010, 6, 154-162.
37. Bedells, A.D.; Arafeh, R.M.; Yang, Z.; Attwood, D.; Heatley, F.; Padget, J.C.; Price, C.; Booth, C. Micellisation of diblock copoly(oxyethylene/oxybutylene) in aqueous solution. J. Chem. Soc. Faraday Trans. 1993, 89, 1235-1242.
38. 13C-NMR spectra of copolymers of ethylene oxide and 1,2-butylene oxide. Eur. Polym. J. 1990, 26, 583-592.
39. Barreto, A.C.H.; Maia, F.J.N.; Santiago, V.R.; Ribeiro, V.G.P.; Denardin, J.C.; Mele, G.; Carbone, L.; Lomonaco, D.; Mazzetto, S.E.; Fechine, P.B.A. Novel ferrofluids coated a renewable material obtained from cashew nut shell liquid. Microfluid Nanofluid 2012, 12, 677-686.